Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies
Ajaykumar N. Sharma, Bruno Fernando Borges da Costa e Silva, Jair C. Soares, et al.
Journal of Affective Disorders (2016) Vol. 197, pp. 9-20
Open Access | Times Cited: 130

Showing 51-75 of 130 citing articles:

Inflammatory markers as predictors of depression and anxiety in adolescents: Statistical model building with component-wise gradient boosting
Consuelo Walss‐Bass, Robert Suchting, Rene L. Olvera, et al.
Journal of Affective Disorders (2018) Vol. 234, pp. 276-281
Open Access | Times Cited: 30
Repeated arctigenin treatment produces antidepressant- and anxiolytic-like effects in mice
Yuru Du, Wenjing Li, Yiming Li, et al.
Brain Research Bulletin (2018) Vol. 146, pp. 79-86
Closed Access | Times Cited: 30
Molecular Biomarkers of Electroconvulsive Therapy Effects and Clinical Response: Understanding the Present to Shape the Future
Elisabetta Maffioletti, Rosana Carvalho Silva, Marco Bortolomasi, et al.
Brain Sciences (2021) Vol. 11, Iss. 9, pp. 1120-1120
Open Access | Times Cited: 22
The VEGF protein levels, miR-101-3p, and miR-122-5p are dysregulated in plasma from adolescents with major depression
Michaela Krivosova, Jana Adamčáková, Erik Kaadt, et al.
Journal of Affective Disorders (2023) Vol. 334, pp. 60-68
Open Access | Times Cited: 9
Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression
Lucia Carboni, Luca Marchetti, Mario Lauria, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 10, pp. 2134-2145
Open Access | Times Cited: 27
The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors
Marissa Giovanna Schamne, Josiel Mileno Mack, Morgana Moretti, et al.
Neurotoxicity Research (2018) Vol. 34, Iss. 4, pp. 808-819
Closed Access | Times Cited: 26
Taekwondo Training Improves Mood and Sociability in Children from Multicultural Families in South Korea: A Randomized Controlled Pilot Study
Hee‐Tae Roh, Su-Youn Cho, Wi-Young So
International Journal of Environmental Research and Public Health (2018) Vol. 15, Iss. 4, pp. 757-757
Open Access | Times Cited: 24
Growth factors and neurotrophins in patients with stress-related exhaustion disorder
Anna Sjörs, Kaj Blennow, Henrik Zetterberg, et al.
Psychoneuroendocrinology (2019) Vol. 109, pp. 104415-104415
Open Access | Times Cited: 23
The protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder
Yanran Zhang, Haitang Jiang, Yingying Yue, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 23
Antidepressant and anxiolytic effects of the proprietary Chinese medicine Shexiang Baoxin pill in mice with chronic unpredictable mild stress
Xidan Zhou, Dongdong Shi, Zhang‐Jin Zhang
Journal of Food and Drug Analysis (2018) Vol. 27, Iss. 1, pp. 221-230
Open Access | Times Cited: 22
Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders
Т. А. Lisitsyna, D. Veltishchev, А. М. Лила, et al.
Rheumatology Science and Practice (2019) Vol. 57, Iss. 3, pp. 318-327
Closed Access | Times Cited: 22
Mirtazapine increases glial cell line-derived neurotrophic factor production through lysophosphatidic acid 1 receptor-mediated extracellular signal-regulated kinase signaling in astrocytes
Kazue Hisaoka‐Nakashima, Sayaka Taki, Shintaro Watanabe, et al.
European Journal of Pharmacology (2019) Vol. 860, pp. 172539-172539
Closed Access | Times Cited: 21
Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy—A pilot study
Laura Kranaster, Kaj Blennow, Henrik Zetterberg, et al.
Journal of Affective Disorders (2019) Vol. 253, pp. 449-453
Open Access | Times Cited: 20
CREB-mediated generation and neuronal growth regulates the behavioral improvement of geniposide in diabetes-associated depression mouse model
Bo Sun, Xiayan Jia, Fei Yang, et al.
Neuroscience Research (2020) Vol. 165, pp. 38-44
Closed Access | Times Cited: 20
The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy
Alexandra S. Troyan, Oleg A. Levada
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 20
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response
Elisabetta Maffioletti, Massimo Gennarelli, Chiara Magri, et al.
Drug Development Research (2020) Vol. 81, Iss. 5, pp. 593-599
Closed Access | Times Cited: 19
Sensory Neuromodulation
Robert D. Black, Lesco L. Rogers
Frontiers in Systems Neuroscience (2020) Vol. 14
Open Access | Times Cited: 19
Neurotrophic and inflammatory markers in bipolar disorder: A prospective study
Seline van den Ameele, Violette Coppens, Jeroen Schuermans, et al.
Psychoneuroendocrinology (2017) Vol. 84, pp. 143-150
Closed Access | Times Cited: 20
Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia
Wenhuan Xiao, Qiongqiong Zhan, Fei Ye, et al.
European Neuropsychopharmacology (2018) Vol. 28, Iss. 5, pp. 603-609
Closed Access | Times Cited: 19
Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study
Oleg A. Levada, Alexandra S. Troyan, Ірина Пінчук
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Bidirectional motivated bimodal isothermal strand displacement amplifier with a table tennis-like movement for the ultrasensitive fluorescent and colorimetric detection of depression-related microRNA
Xiao-Ming Kong, Junfeng Wang, Siwen Lv, et al.
Analytica Chimica Acta (2023) Vol. 1247, pp. 340894-340894
Closed Access | Times Cited: 6
Vascular Endothelial Growth Factor (VEGF) in Neurodevelopmental Disorders
Kristy R. Howell, Jennifer Armstrong
Current Behavioral Neuroscience Reports (2017) Vol. 4, Iss. 4, pp. 299-308
Closed Access | Times Cited: 18
Decreased plasma glial cell line-derived neurotrophic factor level in major depressive disorder is associated with age and clinical severity
Jiaze Sun, Lingtao Kong, Feng Wu, et al.
Journal of Affective Disorders (2018) Vol. 245, pp. 602-607
Closed Access | Times Cited: 17
Altered serum levels of vascular endothelial growth factor and glial-derived neurotrophic factor but not fibroblast growth factor-2 in treatment-naive children with attention deficit/hyperactivity disorder
Nihal Yurteri, İbrahim Şahin, Ali Evren Tufan
Nordic Journal of Psychiatry (2019) Vol. 73, Iss. 4-5, pp. 302-307
Closed Access | Times Cited: 16
Human Fetal Bone Marrow-Derived Mesenchymal Stem Cells Promote the Proliferation and Differentiation of Pancreatic Progenitor Cells and the Engraftment Function of Islet-Like Cell Clusters
Xing Yu Li, Shang Ying Wu, Po Sing Leung
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4083-4083
Open Access | Times Cited: 16

Scroll to top